company background image
540686

Smruthi Organics BSE:540686 Stock Report

Last Price

₹162.25

Market Cap

₹1.9b

7D

-1.4%

1Y

-44.3%

Updated

01 Feb, 2023

Data

Company Financials

540686 Stock Overview

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India.

540686 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

My Notes

New

Notes are coming soon

Smruthi Organics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Smruthi Organics
Historical stock prices
Current Share Price₹162.25
52 Week High₹311.00
52 Week Low₹145.20
Beta1.33
1 Month Change-5.20%
3 Month Change-23.88%
1 Year Change-44.26%
3 Year Change302.11%
5 Year Change469.30%
Change since IPO179.58%

Recent News & Updates

Recent updates

Shareholder Returns

540686IN PharmaceuticalsIN Market
7D-1.4%-1.8%-3.7%
1Y-44.3%-7.6%-2.2%

Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned -7.6% over the past year.

Return vs Market: 540686 underperformed the Indian Market which returned -2.2% over the past year.

Price Volatility

Is 540686's price volatile compared to industry and market?
540686 volatility
540686 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.3%

Stable Share Price: 540686 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 540686's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989290Purushotham Eagahttps://www.smruthiorganics.com

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, teneligliptin, dapagliflozin, and vildagliptin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.

Smruthi Organics Limited Fundamentals Summary

How do Smruthi Organics's earnings and revenue compare to its market cap?
540686 fundamental statistics
Market Cap₹1.86b
Earnings (TTM)₹81.66m
Revenue (TTM)₹1.44b

22.7x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
540686 income statement (TTM)
Revenue₹1.44b
Cost of Revenue₹898.89m
Gross Profit₹543.73m
Other Expenses₹462.07m
Earnings₹81.66m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 09, 2023

Earnings per share (EPS)7.13
Gross Margin37.69%
Net Profit Margin5.66%
Debt/Equity Ratio8.3%

How did 540686 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

33%

Payout Ratio